Understand the source comparison
Comparison: DSIP Half-Life vs Other Sleep-Modulating Peptides
DSIP 15–30 minutes 6–8 hours GABAergic/serotonergic neuromodulation; hypothalamic signaling cascade 30–60 min before sleep Effects persist long after plasma clearance due to downstream pathway activation Melatonin 20–50 minutes 3–5 hours MT1/MT2 receptor agoni
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSIP
- 15–30 minutes
- 6–8 hours
- GABAergic/serotonergic neuromodulation; hypothalamic signaling cascade
- 30–60 min before sleep
- Effects persist long after plasma clearance due to downstream pathway activation
- Melatonin
- 20–50 minutes
- 3–5 hours
- MT1/MT2 receptor agonist; direct circadian reset
- 60–90 min before sleep
- Receptor-mediated effect. Duration tracks plasma concentration more closely
- Orexin antagonists (e.g., suvorexant)
- 12 hours
- 8–10 hours
- Orexin receptor blockade
- At bedtime
- Long half-life creates next-day residual effects; mechanism requires continuous receptor occupancy
- Selank (nootropic peptide)
- 30–40 minutes
- 4–6 hours
- Anxiolytic via GABAergic modulation
- Morning or mid-day
- Similar rapid clearance with extended functional effect via neuromodulation
- CJC-1295 (GH secretagogue)
- 6–8 days
- Pulsatile GH release over 7+ days
- GHRH receptor agonist with albumin binding
- Once weekly
- Extended half-life due to albumin conjugation. Fundamentally different PK profile
- DSIP's profile most closely resembles Selank: short plasma half-life, extended functional duration through neuromodulatory cascades rather than receptor occupancy. This distinguishes it from receptor agonists like melatonin, where effect duration correlates tightly with plasma presence. For researchers comparing sleep peptides, understanding this mechanistic difference prevents protocol design errors. DSIP doesn't require the continuous dosing schedule its 15-minute half-life might imply.